An oncogene in the sights of new anticancer treatments

The RAS oncogene is a gene involved in the development of one out of four cancers and therefore represents a prime target for the development of new anticancer drugs. After 30 years of research efforts, two recent studies suggest that these new treatments could finally be envisioned. Download the column

10-Feb-2020 |

Share this content!

Recent Articles

Column Archives

Column Keywords